Thoracolumbar Spine Procedures
Showing all 8 results
Orthobiologics Market Analysis, Size, Trends | China | 2020-2026 | MedSuite
In 2020, the Chinese orthobiologics market size was valued at $460.7 million, with over 424,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 6% to reach $690.8 million in 2026. Throughout this medical market research, we analyzed 28 orthobiologics companies across China
more...Orthobiologics Market Analysis, Size, Trends | India | 2020-2026 | MedSuite
In 2020, the Indian orthobiologics market size was valued at $76.2 million, with over 520,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 12.4% to reach $172.3 million in 2026. Throughout this medical market research, we analyzed 23 orthobiologics companies across India
more...Orthobiologics Market Analysis, Size, Trends | Japan | 2020-2026 | MedSuite
In 2020, the Japanese orthobiologics market size was valued at $426.9 million, with over 221,000 bone grafting procedures performed every year. The market size is expected to fluctuate over the forecast period with a -0.4% compound annual growth rate (CAGR). Throughout this medical market research, we analyzed 16 orthobiologics companies across Japan and used our
more...Orthobiologics Market Analysis, Size, Trends | South Korea | 2020-2026 | MedSuite
In 2020, the South Korean orthobiologics market size was valued at $141.6 million, with over 200,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.6% to reach $181.5 million in 2026. Throughout this medical market research, we analyzed 16 orthobiologics companies across
more...Orthobiologics Market Analysis, Size, Trends | Australia | 2020-2026 | Medsuite
In 2020, the Australian orthobiologics market size was valued at $63.8 million, with over 29,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 4.9% to reach $89.4 million in 2026. Throughout this medical market research, we analyzed 48 orthobiologics companies across Australia
more...Orthobiologics Market Size, Share & COVID19 Impact Analysis | Europe | 2019-2025 | MedSuite | Includes: Orthopedic Bone Graft Substitutes (Allograft Bone Graft Substitute, Synthetic Bone Graft Substitute, and Demineralized Bone Graft Substitute Bone Matrix), Hyaluronic Acid Viscosupplementation, Bone Morphogenic Protein Growth Factor Therapy & Cartilage Repair (Segmented by Osteochondral Allografts, Meniscal Allografts, Autologous Chondrocyte Implantations, and Osteochondral Autografts)
The total European orthobiologics market is growing at a rate of 1.6%, which will take the 2018 market value of €521.2 million up to €582.3 million by 2025. Constraints on reimbursements will continue to limit the European orthobiologics market. Presently, only a few premium products under the umbrella of pharmaceuticals are reimbursed by the government
more...Orthopedic Biomaterials Market Size, Share & COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Orthopedic Bone Graft Substitutes (Allografts, Demineralized Bone Matrices (DBMs), Xenografts, and Synthetic Bone Graft) , Orthopedic Growth Factor, and 4 more
Overall, the U.S. Orthopedic Biomaterials market was valued at $3.7 billion in 2021. This is expected to increase over the forecast period at a CAGR of 3.6% to reach $4.7 billion. Demographic factors in the U.S. continue to be the largest driver within the orthopedic biomaterials market. This is primarily due to the growing elderly
more...Orthobiologics Market Analysis, Size, Trends | Global | 2019-2025 | MedSuite
Industry Trends A particular trend in the U.S. orthobiologics market is competitors that are seeking to penetrate high growth segments outside their traditional space by distributing existing products manufactured by other companies, rather than creating their own. This often involves partnering with a company by taking on the costs associated with regulation and market approval,
more...